Arrowhead Pharmaceuticals, Inc. (ARWR)

Arrowhead Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	71.37	88.71	76.21	110.89	108.01	184.43
Short-Term Investments	714.97	692.82	578.28	292.74	268.39	183.36
Cash & Short-Term Investments	786.34	781.52	654.48	403.63	376.4	367.79
Cash Growth	42.21%	19.41%	62.15%	7.23%	2.34%	16.58%
Accounts Receivable	218.87	6.82	-	-	1.41	10.26
Other Current Assets	169.18	162.29	40.99	12.85	27.49	6.55
Total Current Assets	1,174	950.64	695.47	416.47	405.3	384.6
Net Property, Plant & Equipment	421.95	426.41	431.56	335.56	168.59	66.02
Other Intangible Assets	6.44	6.86	2.56	10.26	11.96	13.66
Long-Term Investments	-	-	-	-	105.87	245.6
Other Long-Term Assets	1.41	1.39	4.48	3.26	0.22	0.27
Total Assets	1,604	1,385	1,140	765.55	691.94	710.15
Accounts Payable	32.94	17.67	11.39	35.87	2.87	9.46
Accrued Expenses	144.35	117.31	85.01	57.73	59.11	23.77
Short-Term Debt	40	40	-	-	-	-
Current Portion of Leases	7.53	7.29	6.34	10.56	2.78	2.25
Unearned Revenue	111.93	2.4	-	0.87	74.1	111.06
Other Current Liabilities	10.68	10.81	0.43	0.44	-	-
Total Current Liabilities	347.43	195.49	103.17	105.46	138.85	146.54
Long-Term Debt	538.11	582.28	734.54	268.33	-	-
Long-Term Leases	102.13	104.11	111.03	104.61	78.8	23.3
Other Long-Term Liabilities	53.83	-	-	-	55.95	131.5
Total Long-Term Liabilities	694.06	686.39	845.57	372.93	134.75	154.79
Total Liabilities	1,041	881.88	948.74	478.39	273.6	301.33
Common Stock	0.23	0.23	0.22	0.2	0.2	0.2
Treasury Stock	-53.19	-53.19	-	-	-	-
Additional Paid-in Capital	2,211	2,140	1,806	1,300	1,219	1,053
Accumulated Other Comprehensive Income	6.7	6.44	2	-3.22	-0.14	-0.07
Retained Earnings	-1,596	-1,627	-1,626	-1,026	-820.76	-644.69
Total Common Shareholders' Equity	568.42	466.05	182.69	271.34	398.52	408.82
Minority Interest	-5.73	37.36	8.37	15.82	19.82	-
Shareholders' Equity	562.7	503.42	191.06	287.16	418.34	408.82
Total Liabilities & Equity	1,604	1,385	1,140	765.55	691.94	710.15
Total Debt	687.76	733.68	851.91	383.5	81.58	25.55
Net Cash (Debt)	98.57	47.84	-197.43	20.13	294.82	342.24
Net Cash Growth	106.04%	-	-	-93.17%	-13.86%	16.27%
Net Cash Per Share	0.72	0.36	-1.65	0.19	2.80	3.30
Book Value	568.42	466.05	182.69	271.34	398.52	408.82
Book Value Per Share	4.14	3.48	1.53	2.54	3.78	3.94
Tangible Book Value	561.99	459.19	180.13	261.08	386.56	395.16
Tangible Book Value Per Share	4.09	3.43	1.50	2.45	3.67	3.81

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q